A report released by the nonprofit group No Patient Left Behind has claimed that it has found critical flaws in a key metric used by US insurance companies and 2 April 2024

Pharmaceutical

Guidance needed to ensure EU’s JCA improves access to innovative cancer treatments

Guidance needed to ensure EU’s JCA improves access to innovative cancer treatments 2 April 2024

Biotechnology

Fiocruz and Caring Cross join forces to produce affordable CAR-T therapy

Fiocruz and Caring Cross join forces to produce affordable CAR-T therapy 27 March 2024

Pharmaceutical

Half trillion dollar PBM sector continues to grow

In the fragmented and complex US healthcare system, the market value of pharmacy benefit managers (PBM) has reached new heights. 25 March 2024

Pharmaceutical

US reimbursement breakthrough for Novo Nordisk's Wegovy

Validating Novo Nordisk’s decision to research the cardiovascular impact of Wegovy (semaglutide), US authorities have said Medicare patients with heart problems 22 March 2024

Generics

European Parliament supports comprehensive reforms for pharma

European Parliament supports comprehensive reforms for pharma 20 March 2024

Pharmaceutical

India's NPPA struggles to recover over 86% of overcharging demands

India's NPPA struggles to recover over 86% of overcharging demands 15 March 2024

Biotechnology

UK HTA looks disfavorably on new sickle cell gene therapies

Britain’s health technology assessor (HTA) is moving to recommend against funding Casgevy (exagamglogene autotemcel), the second such blow for people with sickl 15 March 2024

Previous page 1 234 5 6 7 8 9 10 Next page

Pricing, reimbursement and access

Today's issue

Company Spotlight